1 The remarkably low incidence of hypoglycemia and significant weight loss associated with these agents have contributed to their increased use
It is administered as a once-daily subcutaneous injection, with dose titration to 3 mg
10.1007/s00198-018-4649-8 Summary Keywords glucagon-like peptide-1, diabetes mellitus, glucagon-like peptide 1 receptor agonists, osteoporosis, bone resorption Citation Xie B, Chen S, Xu Y, Han W, Hu R, Chen M, Zhang Y and Ding S (2021) The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
Pristanic acid (2,6,10,14-tetramethylpentadecanoic acid) then serves as a substrate for the peroxisomal process of -oxidation
Expression of results: The content X of L-carnitine in the sample, expressed as mass fraction in mg/100 g, is calculated according to the following formula: Where: X the content of L-carnitine in the sample, in milligrams per hundred grams (mg/100 g)